BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

21 related articles for article (PubMed ID: 8150600)

  • 1. Changes of Blood Pressure and Hemodynamic Parameters after Oral Magnesium Supplementation in Patients with Essential Hypertension-An Intervention Study.
    Banjanin N; Belojevic G
    Nutrients; 2018 May; 10(5):. PubMed ID: 29738504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute hemodynamic effects of nisoldipine in young hypertensive patients.
    Zimlichman R; Zilberman D; Gold B
    Isr J Med Sci; 1995 May; 31(5):288-92. PubMed ID: 7759224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central hemodynamic effects at rest and during exercise of acute and chronic treatment with nisoldipine in essential hypertension.
    Omvik P; Lund-Johansen P; Haugland H
    J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S182-4. PubMed ID: 2455128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamic and plasma renin effects of propranolol in essential hypertension.
    Mookherjee S; Eich RH; Obeid AI; Smulyan H
    Arch Intern Med; 1977 Mar; 137(3):290-5. PubMed ID: 843147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of nisoldipine on ambulatory blood pressure under 24-hour noninvasive monitoring.
    Blau A; Herzog D; Shechter P; Eliahou HE
    Isr J Med Sci; 1992 Oct; 28(10):688-93. PubMed ID: 1399498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nisoldipine. Central haemodynamics at rest and during exercise in essential hypertension: acute and chronic studies.
    Omvik P; Lund-Johansen P; Haugland H
    J Hypertens; 1988 Feb; 6(2):95-103. PubMed ID: 3351300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Peripheral vascular hemodynamics in essential hypertension].
    Yaginuma T
    Nihon Rinsho; 1992 Apr; 50 Suppl():408-13. PubMed ID: 1635223
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical pharmacology of nisoldipine, a new calcium antagonist].
    Krivonkin KIu; Belousov IuB
    Kardiologiia; 1991 Sep; 31(9):100-5. PubMed ID: 1753601
    [No Abstract]   [Full Text] [Related]  

  • 9. Cardiovascular effects of nisoldipine in essential hypertension.
    Blau A; Herzog D; Herz I; Battler A; Schechter P; Eliahou HE
    Isr J Med Sci; 1994 Feb; 30(2):139-45. PubMed ID: 8150600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nisoldipine: a new dihydropyridine calcium-channel blocker.
    Mitchell J; Frishman W; Heiman M
    J Clin Pharmacol; 1993 Jan; 33(1):46-52. PubMed ID: 8429113
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.